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Abstract Reproductive functions are closely related to nutri-
tional status. Recent studies suggest that adiponectin may be a
hormonal l ink between them. Adiponect in is an
adipocytokine, abundantly expressed in adipose tissues. It
plays a dominant role in lipid and carbohydrate metabolism
by stimulating fatty acid oxidation, decreasing plasma triglyc-
erides, and increasing cells’ sensitivity to insulin and has direct
antiatherosclerotic effects. The hormone is also postulated to
play a modulatory role in the regulation of the reproductive
system. The aim of this study was to identify differentially
expressed genes (DE-genes) in response to adiponectin treat-
ment of porcine luteal ovarian cells. The global expression of
genes in the porcine ovary was investigated using the Porcine
(V2) Two-color gene expression microarray, 4×44 (Agilent,
USA). Analysis of the microarray data showed that 701 genes
were differentially expressed and 389 genes showed a fold
change greater than 1.2 (p<0.05). Among this number, 186
genes were up-regulated and 203 were down-regulated. The
list of DE-genes was used for gene ontology analyses. The
biological process list was generated from up-regulated and
down-regulated DE-genes. We found that up-regulated prod-
ucts of DE-genes take part in 30 biological processes and
down-regulated products in 9. Analysis of the interaction net-
work among DE-genes showed that adiponectin interacts with
genes involved in important processes in luteal cells. These
results provide a basis for future work describing the detailed
interactions and relationships explaining local regulation of
adiponectin actions in the ovary of pigs.
Keywords Adiponectin . Porcine luteal cells . Differentially
expressed genes
Introduction
During the last two decades, the view on adipose tissue has
changed from it being a passive reservoir for energy storage to
a complex and highly active metabolic and endocrine organ.
Adipose tissue is now known to express and secrete a variety
of bioactive peptides, i.e., leptin, tumor necrosis factor alpha,
interleukin 6, resistin, adipsin, and adiponectin (Kershaw and
Flier 2004). Adiponectin is an adipocytokine, abundantly
expressed in adipose tissues. It is also one of the most present-
ed proteins in mammalian blood serum (2–25 μg/ml)
(Kadowaki and Yamauchi 2005). The hormone is composed
of 247 amino acids and has a molecular weight of about
28 kDa (Scherer et al. 1995). Adiponectin structurally belongs
to the complement-1q family (Wong et al. 2004). As a result of
post-translation modification, adiponectin circulates in blood
in four different forms. The full-length peptide generates tri-
mers, hexamers, and high-molecular-weight multimers and
the globular fraction product of the proteolytic cleavage of
the full-length peptide (Chandran et al. 2003).
Adiponectin’s physiological effects are dependent on re-
ceptor type 1 (AdipoR1) and type 2 (AdipoR2). AdipoR1
and AdipoR2 proteins in pigs have a molecular mass of 42
and 46 kDa, respectively (Chabrolle et al. 2007a). In humans
and rodents, AdipoR1 is abundantly expressed in the skeletal
muscle, whereas AdipoR2 is predominantly expressed in the
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liver (Yamauchi et al. 2003). Due to the extensive distribution
of adiponectin receptors in the peripheral tissues and organs,
adiponectin exerts pleiotropic effects on the regulation of en-
ergy homeostasis in organisms. It plays a dominant role in
lipid and carbohydrate metabolism by stimulating fatty acid
oxidation, decreasing plasma triglycerides, and increasing
cells’ sensitivity to insulin and has direct antiatherosclerotic
effects (Kadowaki and Yamauchi 2005). Adiponectin is also
involved in the regulation of energy balance and body weight
and additionally plays a modulatory role in the regulation of
the reproductive system (Yamauchi et al. 2001; Kiezun et al.
2014; Maleszka et al. 2014a).
Reproductive functions are closely related to nutritional
status. Recent studies suggest that adiponectin may be a hor-
monal link between them. The presence of adiponectin and its
receptors was found at all levels of the hypothalamic-
pituitary-gonadal (HPG) axis in the pig, human, rat, cow,
and chicken (Ledoux et al. 2006; Chabrolle et al. 2007a,
2007b, 2009; Mailard et al. 2010).
In the hypothalamus, the presence of adiponectin receptors
has been demonstrated in the neurons responsible for the se-
cretion of gonadotropin-releasing hormone (GnRH)
(Kaminski et al. 2014). Adiponectin reduces the secretion of
GnRH in the GT1-7 cell line derived from murine GnRH-
releasing neurons (Wen et al. 2008). The expression of
adiponectin receptors was also found in the pituitary gland,
which allows for the direct effect of the hormone on the se-
cretion of the luteinizing hormone and follicle-stimulating
hormone (Rodriguez-Pacheco et al. 2007; Kiezun et al.
2014). Another proof for the involvement of adiponectin in
the regulation of the HPG axis is the demonstrated presence of
adiponectin receptor protein in human and pig ovaries
(Chabrolle et al. 2009; Maleszka et al. 2014a).
The systematically growing number of publications con-
firms the potential impact of adiponectin on the gene
expression and secretion of hormones connected to
reproductive functions. Ledoux et al. (2006) observed higher
levels of prostaglandin-endoperoxide synthase 2 (PTGS2),
prostaglandin E synthase (PTGES), and vascular endothelial
growth factor (VEGF) gene expression in granulosa cells
primed with adiponectin, an increase in the expression of the
steroidogenic acute regulatory protein (StAR) gene, and a de-
crease in the expression of the P450 aromatase gene in granu-
losa cells derived from prepubertal gilts. Adiponectin was also
found to affect the basal and stimulated secretion of steroid
hormones, i.e., progesterone, estradiol, androstenedione, and
testosterone, by ovarian cells of mature gilts (Maleszka et al.
2014a). These results undoubtedly confirm the involvement of
adiponectin in the functioning of the reproductive system.
Despite the above, there is a lack of data concerning
adiponectin’s influence on the transcriptome profile of the
HPG axis cells, including ovarian cells. Knowledge about
the impact of adiponectin on the functioning of the ovaries is
fragmentary and needs more research based on microarray
methods. The results of these studies may become a starting
point for more detailed research clarifying these relationships.
Thus, using the pig as a model, and a transcriptomic approach,
the aim of this study was to identify differentially expressed
genes during adiponectin treatment of porcine luteal cells.
Materials and methods
Experimental animals
All experiments were carried out in accordance with the prin-
ciples of the ethical standards of the Animal Ethics Committee
at the University of Warmia and Mazury in Olsztyn. The ex-
perimental material comprised mature gilts (Large
White×Polish Landrace) from a private breeding farm, aged
7–8 months and weighing 130–140 kg. All of the gilts used in
the experiment were on days 10 to 12 of the estrous cycle
(n=4). Females were monitored daily for estrous behavior
in the presence of an intact boar. The day of the second estrous
was designated as day 0 of the estrous cycle. The phase of the
estrous cycle was also determined based on the ovarian mor-
phology (Akins and Morrissette 1968). The ovaries were re-
moved and placed on ice within minutes after slaughter.
Subsequently, the ovaries from days 10 to 12 of the cycle were
placed in cold PBS buffer and transported to the laboratory
where luteal cells were isolated.
Isolation of the luteal cells
Luteal cells were isolated using the method described by
Kaminski et al. (1999). Dissected corpora lutea were minced
into small fragments and dispersed in F-12 medium (Sigma,
USA) containing bovine serum albumin fraction V (BSA;
1 %; MP Biomedicals, USA) and antibiotics (Sigma, USA).
Corpora lutea were enzymatically dissociated in 0.125% tryp-
sin solution (Biomed Lublin, Poland) (four to six times) at
37 °C, centrifuged (300×g, 10 min, 4 °C), and washed three
times. Isolated luteal cells were filtered through the nylon
mesh (40 μm in diameter) and resuspended in the fresh F-12
medium. The cells were counted using a hemocytometer, and
their viability (∼90 %) was determined by 0.4 % trypan blue
dye exclusion.
In vitro cultures of the luteal cells
Isolated luteal cells (1,500,000/1 mL medium) were resus-
pended in F-12 medium enriched with fetal calf serum
(FCS; 20 %; Sigma USA), BSA (1 %) and antibiotics and
preincubated in the 6-well plates for 48 h in a humidified
incubator with 95 % air and 5 % CO2 atmosphere. The
serum-containing medium was discarded, and the cells were
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washed using serum-free F-12 medium. After washing, the
cells were cultured for 24 h in F-12 medium with BSA
(1 %) with antibiotics, with or without (control) recombinant
human adiponectin (BioVendor, USA) at the dose of
10 μg/ml. Cultures for each individual were performed in
duplicate. The dose of adiponectin was equivalent to physio-
logical concentration (Maleszka et al. 2014b). The alamarBlue
test (MP Biomedicals, USA) revealed that the treatment did
not affect the viability of the cultured cells. The alamarBlue
test was performed as described by Rak and Gregoraszczuk
(2008), with the modification of cell preincubation and proper
incubation time (24 h each). The measurement of the absor-
bance was performed using an Infinite 200 PRO plate reader
(Tecan Group, Switzerland) at wavelengths 570 and 600 nm.
Total RNA isolation and quality control
Total RNA was extracted from cells using the RNeasy Mini
Kit (Qiagen, USA) and purified by on-column digestion of
DNA with DNase I as recommended by the manufacturer
(Qiagen, USA) to eliminate residual genomic DNA. The ini-
tial RNA quality and quantity were determined with spectro-
photometry (Infinite 200 PRO plate reader with NanoQuant
plates, Tecan Group, Switzerland). Subsequently, RNA qual-
ity was checked on an Agilent 2100 Bioanalyzer (Agilent
Technologies, USA) using RNA 6000 Nano Assay Kit
(Agilent Technologies, USA). RNAs with an RNA integrity
number (RIN) score between 8 and 10 were used for micro-
array and quantitative real-time PCR (qPCR) experiments. All
RNAs were stored at −80 °C.
Microarray analysis
Total RNA was amplified and labeled using a Low Input
Quick Amp, Two-Color kit (Agilent Technologies, USA) ac-
cording to the manufacturer’s instructions. The sample and
control RNAs were labeled with Cyanine-5 (Cy-5) and
Cyanine-3 (Cy-3), respectively. Quantity and purity of
cRNAwere measured with Infinite 200 PRO plate reader with
NanoQuant plates (Tecan Group, Switzerland). For each mi-
croarray, 825 ng of Cy-3 and 825 ng of Cy-5-labeled cRNA
were mixed together. Dual-labeled cRNA was fragmented,
mixed with hybridization buffer, and added to Porcine (V2)
Gene Expression Microarray 4x44 (Agilent Technologies,
USA) according to the manufacturer’s instructions. Two dif-
ferentially labeled cRNA samples (obtained from treated and
control samples) were placed on each array (n=4, one slide)
in a balanced block design with dye swaps (Supplementary
Data 1). Hybridization was carried out at 60 °C for 17 h in an
Agilent hybridization oven. Hybridized microarrays were dis-
sociated form the hybridization chamber and washed. After
washing, slides were scanned at 5 μm resolution with an
Agilent’s High-Resolution C Microarray Scanner. The TIFF
image generated was loaded into Feature Extraction Software
(Agilent Technologies, USA) for feature data extraction and
detailed analysis, background subtraction from features, and
dye normalizations (linear and LOWESS).
Bioinformatic analysis
The expression data was loaded into GeneSpring GX 12 soft-
ware (Agilent Technologies, USA) to determine which genes
were differentially expressed between treated and control
samples. Differentially expressed transcripts were identified
by cutoff of fold change (FC) greater than 1.2 in up- or
down-regulation and p value <0.05. The 1.2 FC cutoff was
chosen based on other publications, which used the microar-
ray technology (Franczak et al. 2014; Jeong et al. 2006; Kimsa
et al. 2013). Student’s t test was used to compare the normal-
ized fluorescence intense for adiponectin treated versus con-
trol samples. FC was calculated based on the mean values of
the treated/control gene expression levels of four biological
replicates. For genes with replicate probes on the array, which
showed differential expression, the FC mean value of all the
probes was calculated.
Gene ontology analysis
The list of differentially expressed genes (DE-genes) was
uploaded into Database for Annotation, Visualization, and
Integrated Discovery (DAVID, http://david.abcc.ncifcrf.gov)
to explore functional class scoring in the resulting gene list
by means of GO term enrichment analysis (Huang et al.
2009). Significance levels were calculated following a modi-
fication of Fisher’s exact test.
Biological pathways analysis
DAVID was additionally used to explore the biological path-
ways enriched in the resulting gene list, using information
from each individual gene and computing a total overrepre-
sentation value for each pathway represented in the Kyoto
Encyclopedia of Genes and Genomes (KEGG, http://www.
genome.jp/kegg) and BioCarta (http://www.biocarta.com).
Significance levels were calculated following a modification
of Fisher’s exact test. As a complementary approach,
Ingenuity Pathway Analysis (IPA, http://www.ingenuity.
com/) bioinformatic tools were employed to explore the
distribution of differentially expressed genes in well-reported
canonical signal transduction or metabolic pathways integrat-
ing fold-change data from the microarray experiment and
gene-to-gene or protein-to-protein interaction information
generated from the literature databases. In this approach,
statistical significance of pathway overrepresentation
was established with respect to a null distribution con-
structed by permutations.
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Interaction network of differentially expressed genes
IPA was used to examine molecular pathways. This software
combines functional annotations of our differentially
expressed genes and the corresponding bibliographic data to
generate significant signaling pathways and regulation
networks.
Real-time PCR validations
In order to confirm microarray results, nine genes were tested
for validation by qPCR by using the same samples used for
microarray studies. One microgram of total RNA samples
(n = 4 for treated and n= 4 for the control) was reverse-
transcribed into cDNA in a total volume of 20μ L with
0.5μ g oligo(dt)15 Primer (Roche, Germany) using the
Omniscript RT Kit (Qiagen, USA) at 37 °C for 1 h and was
terminated by incubation at 93 °C for 5 min. qPCR analysis
was performed using PCR System 7300 and SYBR® Green
PCR Master Mix (Applied Biosystems, USA). The PCR re-
action included the following: 20 ng cDNA (all genes with the
exception of nuclear receptor coactivator 3 (NCOA3 40 ng)),
one of nine primer pairs (forward and reverse): angiotensin-
converting enzyme (ACE)—500 nM, aldo-keto reductase
family 1, member C1 (AKR1C1)—500 nM, prostaglandin-
endoperoxide synthase 2/cyclooxygenase-2 (PTGS2/
COX2)—500 nM, glutamine-fructose-6-phosphate amino-
transferase 1 (GFPT1)—500 nM, interleukin 15 (IL15)—
500 nM, NCOA3—250 nM, methylmalonyl-CoA mutase
(MUT)—100 nM, nicotinamide phosphoribosyltransferase/
visfatin (NAMPT)—300 nM, vascular endothelial growth fac-
tor α (VEGFα)—500 nM, 12.5 μl SYBR Green PCR Master
Mix (Applied Biosystems, USA), and RNase free water to a
final volume of 25 μl. Selected forward and reverse primers,
as well as qPCR conditions, are presented in Table 1.
Constitutively expressed genes, β-actin and glyceraldehyde
3-phosphate dehydrogenase (GAPDH), were used as an inter-
nal control to verify the quantitative real-time PCR. To ensure
that β-actin andGAPDHwere suitable reference genes for this
study, we revealed that there were no statistically significant




Description of differentially expressed genes
A table containing a complete list of genes that were differen-
tially expressed between controls and the cells treated with
10 μg/ml of adiponectin is presented in Supplementary Data
2. The table includes a probe set name, gene ID, fold change,
the direction of change (up or down), p value, as well as
function and accession number. Out of these 701 genes, 389
genes were a fold change greater than 1.2 (p<0.05); among
this number, 186 genes were up-regulated and 203 were
down-regulated.
Gene ontology analysis
GO term annotations were used to perform a functional cate-
gorization of the resulting list of differentially expressed gene
analysis. Three GO categories (biological process, metabolic
function, and cell component) were explored with DAVID
bioinformatic tools for overrepresentation of specific GO
terms. Significant results for the whole DE-gene list (up- and
down-regulated; modified Fisher exact p<0.1) are summa-
rized in Supplementary Data 3. The most relevant results were
obtained under the biological process category. Additionally,
the biological process lists from up-regulated and down-
regulated differentially expressed genes (DE-genes) were gen-
erated (Table 2). In the analysis conducted on the basis of the
up-regulated DE-gene list, we observed a group of nine genes
associated with GO terms related to macromolecular complex
subunit organization (GO:0043933). Most of these are in-
volved in the protein complex assembly (GO:000646), which
suggests that adiponectin induces the formation of new pro-
tein complexes in luteal cells. Moreover, the same group of
gene products is associated with the protein complex
biosynthesis (GO:0070271), which indicates the involvement
of adiponectin not only in the formation of protein complexes
but also in the biosynthesis of new proteins. The next group of
seven-gene products is involved in cytoskeleton organization
(GO:0007010), including four engaged in the actin cytoskel-
eton organization (GO:0030036) process. The same group of
four-gene products is involved in the actin filament-based
process (GO:0030029). It seems that adiponectin may influ-
ence luteal cells via reorganization of their cytoskeleton.
Another biological process modulated by the studied hormone
is cell proliferation (GO:0008283). We have identified six up-
regulated DE-genes related to this GO term. Another five-
gene products are associated with blood circulation
(GO:0008015), including three involved in the regulation of
blood pressure (GO:0008217). Additionally, the next group of
three-gene products is involved in the tissue remodeling, with
two of them engaged in the blood vessel remodeling
(GO:0001974). This suggests that the transport of nutrients
and the removal of waste products from the highly metabolic
luteal cells, regulated by the products of these two genes
groups, may be affected by adiponectin. The adipokine in-
creased the expression of five genes, whose products are in-
volved in the cell response to hypoxia (GO:0001666).
Another group of four genes is associated with GO term relat-
ed to lipid localization (GO:0010876). It suggests that
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adiponectin may affect essential condition discharge of luteal
cell steroidogenesis, which is the access to lipid. The next
group of four-gene products is involved in the epithelium
development (GO:0060429); three of these gene products are
connected with epithelial cell differentiation (GO:0030855).
Adiponectin has also an effect on the reproductive develop-
mental processes (GO:0003006) by increasing the expression
of four DE-genes. Three of these DE-genes affect gonad
development (GO:0008406), development of primary sexual
characteristic (GO:0045137), and reproductive structure
Table 1 Primers used for the validation of microarray results
Gene
symbol




R: 5′-TAGCAGCAGGGTGTAGCTTC-3′ Activation : 95 C˚−10 min
Denaturation : 95 C˚−15 s
Annealing : 60 C˚−1 min







R: 5'-CACTCCACCTGGTTGCAGA-3′ Activation : 95 C˚−10 min
Denaturation : 95 C˚−15 s
Annealing : 60 C˚−1 min







R: 5′-TACTTGGTTGGGTTATG-3′ Activation : 95 C˚−15 min
Denaturation : 95 C˚−15 s
Annealing : 60 C˚−1 min









R: 5′-AAAAGCAGCTCTGGGTCAAA-3′ Activation : 95 C˚−15 min
Denaturation : 95 C˚−15 s
Annealing : 55 C˚−1 min





NM_214321.1 Blitek et al. 2006
MUT F: 5′-GGTCAACAAGGATTATCAGTTGC-3′
R: 5′-GCTGTATATTGGAAGATGTCAGC-3′ Activation : 95 C˚−15 min
Denaturation : 95 C˚−15 s
Annealing : 60 C˚−1 min





NM_214405.1 Naranjo et al. 2006
IL15 F: 5′-GCTCATCCCAATTGCAAAGT-3′
R: 5′-TTCCTCCAGCTCCTCACATT-3′ Activation : 95 C˚−15 min
Denaturation : 94 C˚−15 s
Annealing : 58 C˚−30 s








R: 5′-CATCAACTCCCACACCAGCA-3′ Activation : 95 C˚−10 min
Denaturation : 95 C˚−15 s
Annealing : 60 C˚−1 min









R: 5′-AAATTCCCTCCTGGTGTCCTATG-3′ Activation : 50 C˚−2 min; 95 C˚−10 min
Denaturation : 95 C˚−15 s
Annealing : 60 C˚−1 min

40 cycles
NM_001031793.2 Palin et al. 2008
VEGFA F: 5′-GAGACCAGAAACCCCACGAA-3′
R: 5′-GGC AGTAGCTGCGCTGGTA-3′ Activation : 42 C˚−30 min
Denaturation : 95 C˚−15 s
Annealing : 60 C˚−30 s





NM_214084 Liu et al. 2011
β-actin F: 5'-ACATCAAGGAGAAGCTCTGCTACG-3′
R: 5′-GAGGGGCGATGATCTTGATCTTCA-3′ Activation : 95 C˚−10 min
Denaturation : 95 C˚−15 s
Annealing : 61 C˚−1 min








R: 5′-CCACAACATACGTAGCACCAGCATC-3′ Activation : 95 C˚−10 min
Denaturation : 95 C˚−15 s
Annealing : 59 C˚−1 min

40 cycles
U48832 Nitkiewicz et al. 2010
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development (GO:0048608). Another biological process
worth emphasizing is the female pregnancy (GO:0007565),
which is represented by three DE-genes. Moreover, three
DE-genes are involved in the regulation of smooth muscle cell
prol i feration (GO :0048660) , kidney development
(GO:0001822), and nucleobase, nucleotide, and nucleic acid
transport (GO:0015931). The last two significant results were
related to the positive regulation of endothelial cell
proliferation (GO:0001938) and glycosphingolipid metabolic
process (GO:0006687). In the case of GO analysis of down-
regulated DE-genes, the most significant group consisted of
five genes, the products of which are involved in cell death
(GO:0008219). Additionally, adiponectin decreased the ex-
pression of four genes connected to the GO term cell cycle
process (GO:0022402). The adipokine down-regulated four
DE-genes associated with the generation of precursor metab-
olites and energy (GO:0006091). Three of these genes are
rela ted to the energy reserve metabol ic process
(GO:0006112). Other processes affected by DE-genes are glu-
tamine metabolic process (GO:0006541), cellular amide met-
abolic process (GO:0043603), and immunoglobulin-mediated
immune response (GO:0016064), two DE-genes for each pro-
cess. In summary, many up-regulated by adiponectin
biological processes were related to the development and pro-
liferation, whereas those connected to the cell death and cata-
bolic processes were down-regulated. The above is consistent
with the role of adiponectin as a factor promoting reproduc-
tion under proper nutritional conditions.
Biological pathway analysis
To generate biological pathway analysis, we used three differ-
ent databases, which were KEGG, BioCarta, and IPA. The
results are compared in Table 3. DAVID software generated
three pathways based on KEGG database: purine metabolism
(four DE-genes), renal cell carcinoma pathway (three DE-
genes), and pantothenate and CoA biosynthesis (two DE-
genes). In turn, BioCarta database generated one pathway,
which was the transcription regulation by methyltransferase
of CARM1. The second tool IPA software was used to survey
the pathways overrepresented in our DE-gene list. The out-
come of this analysis was a total of 16 pathways. The most
significant was IL-8 signaling pathways (four DE-genes).
Other pathways indicated by IPA tool were as follows: TR/
RXR activation (three DE-genes), PPAR (three DE-genes),
interleukins IL-6 (three DE-genes), and IL-10 signaling path-
ways (two DE-genes). Less significant pathways included i.a.
nitric oxide signaling in the cardiovascular system (three DE-
genes), LXR/RXR activation (three DE-genes), corticotropin-
releasing hormone (three DE-genes), and pancreatic
adenocarcinoma (three DE-genes) signaling, as well as ovar-
ian cancer (three DE-genes). The differences between data
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background to map the queried gene list, different search pa-
rameters, and algorithms used to define pathways in each da-
tabase. In contrast to DAVID, IPA allows to find the pathways
in the determined type of cells.
Network between differentially expressed genes
Differentially expressed genes containing the gene identifiers
along with the corresponding fold changes were uploaded into
the IPA software to annotate bio-functions as well as to con-
struct and visualize molecular interaction networks. The IPA
contains information from scientific publications regarding
direct and indirect relationships between genes and proteins.
Each identifier was mapped to its corresponding gene object
in the IPA base. These genes, called focus genes, were over-
laid onto a global molecular network in the IPA. Networks of
these focus genes were then algorithmically generated based
on their connectivity. A total of eight significant molecular
networks were identified by Fisher’s exact test in the IPA
software (Fig. 1a). The score was transformed from logP.
Figure 1b, c showed two most significant networks, in which
DE-genes were highlighted in red (up-regulated) and green
(down-regulated). The first network (Fig. 1b) was built of 34
genes including 17 genes from the DE-gene list. The analysis
indicated that DE-genes are involved in several bio-functions,
which are cellular assembly and organization, cellular
development, and cellular growth and proliferation. The sec-
ond network (Fig. 1c) was constructed of 29 genes including
15 DE-genes that are involved in cell-mediated immune
response, cellular development, and cellular function and
maintenance. The third network was built of 28 genes and
15 DE-genes, which were also engaged into cellular and tis-
sue development and cancer. The fourth network included 14
DE-genes within 26 genes, which are involved in cancer and
gastrointestinal and infectious disease. The rest of the net-
works were built respectively of 22 genes (12 DE-Genes),
19 genes (11 DE-Genes), 14 genes (9 DE-Genes), and 7 genes
(5 DE-Genes). Top bio-functions were as follows: cancer,
cellular function and maintenance, molecular transport, car-
diovascular diseases, connective tissue disorders, amino-acid
metabolism, cellular development, cell death and survival,
hematological diseases.
Real-time PCR validations
To validate DNA microarray data, nine genes with fold
change greater than 1.2 were chosen for qPCR. The products
of selected genes are involved in processes important for
Table 3 Analysis of pathways significantly enriched in the list of differentially expressed genes
KEGG pathway analysis
KEGG pathway analysis name Gene number p value Altered genes
Pantothenate and CoA biosynthesis 2 4.80E−03 ENPP1, PPCS
Purine metabolism 4 2.20E−02 ENPP1, NPR2, PDE11A, PDE2A
Renal cell carcinoma 3 1.30E−02 CREBBP, PGF, VEGFA
BioCarta pathway analysis
BioCarta pathway analysis name Gene number p value Altered genes
Transcription regulation by methyltransferase of CARM1 2 3.50E−03 CREBBP, NCOA3
Ingenuity canonical pathway analysis
Ingenuity canonical
pathway name
Gene number p Value Altered genes
TR/RXR activation 3 8.76E−03 UCP3, AKR1C1/AKR1C2, NCOA3
PPAR signaling 3 1.15E−02 IL1β, PTGS2, MAP4K4
IL-8 signaling 4 1.32E−02 VEGFA, PTGS2, MAP4K4, PGF
Nitric oxide signaling in the cardiovascular system 3 1.32E−02 VEGFA, PDE2A, PGF
Pancreatic adenocarcinoma signaling 3 1.59E−02 VEGFA, PTGS2, PGF
IL-6 signaling 3 2.01E−02 VEGFA, IL1β, MAP4K4
Role of hypercytokinemia/hyperchemokinemia in the pathogenesis of influenza 2 2.11E−02 IL1β, IL15
LXR/RXR activation 3 2.25E−02 IL1β, MSR1, PTGS2
Ovarian cancer signaling 3 2.76E−02 VEGFA, PTGS2, PGF
Relaxin signaling 3 2.98E−02 VEGFA, PDE2A, NPR2
Role of cytokines in mediating communication between immune cells 2 3.16E−02 IL1β, IL15
Mitotic roles of polo-like kinase 2 4.27E−02 PLK1, RAD21
Prostanoid biosynthesis 1 4.38E−02 PTGS2
IL-10 signaling 2 4.62E−02 IL1β, MAP4K4
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ovarian tissue functions, such as renin-angiotensin system
(ACE), metabolism of lipids, carbohydrates, and protein
(MUT, GFPT1, NAMPT), steroid hormone metabolism and
action (AKR1C1, NCOA3), prostaglandin synthesis and me-
tabolism (PTGS2), and interleukin and growth factor action
(IL15, VEGFA). All changes in gene expression determined by
DNA microarray were confirmed by qPCR (Fig. 2). All sam-
ples were amplified in duplicate. The specificity of amplifica-
tion was tested at the end of the PCR by melting curve anal-
ysis. Levels of gene expression were calculated using the
ΔΔCt method and normalized using the geometrical means
of reference gene expression levels: β-actin and GAPDH. The
Ct values for all non-template controls were under the detec-
tion threshold. Data are presented as means ±S.E.M. from
four different observations. Differences between treated sam-
ple and control were analyzed by one-way ANOVA followed
by least significant differences (LSD) post hoc test. Statistical
analyses were performed using STATISTICA Software
(StatSoft Inc., Tulsa, USA). Values of p<0.05 were consid-
ered as statistically significant.
Discussion
The aim of this study was to determine for the first time the
influence of adiponectin on the transcriptomic profile of luteal
ovarian cells. An Agilent DNA microarray was used to iden-
tify the global gene expression profiles in the samples. In order
to recognize the differentially expressed genes between the
treated and non-treated luteal cells from the mid-luteal phase
(days 10 to 12) of the estrous cycle, we extracted only those
with a fold change above 1.2. The same type of microarray
technology and cutoff 1.2 fold change was used by Franczak
et al. (2014), Jeong et al. (2006), Kimsa et al. (2013). These
allowed us to create a list of genes, which was used to describe
Fig. 1 Interaction networks of selected genes. a Top network
associations identified in microarray study; b the most significant
molecular network by IPA pathway enrichment analysis; c the second
most significant molecular network. Differentially expressed genes
were highlighted in red (up-regulated) and green (down-regulated)
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gene ontology, biological pathways, and possible interaction
networks.
We observed that 701 genes were differentially expressed.
Among this number, the expression of 389 genes was altered
by 1.2-fold in treated versus non-treated samples. Of them,
186 were up-regulated, whereas 203 were down-regulated.
Other microarray analyses of the ovarian tissues conducted
by Caetano et al. (2004) and Agca et al. (2006) indicated both
quantitative and qualitative variations in the global gene
expression. Agca et al. (2006) studied differences in the global
gene expression between ovarian follicles before and after
luteinization (43 up-regulated and 107 down-regulated genes).
Caetano et al. (2004) observed differences in the various ovar-
ian tissues gene expression during days 2–6 of the luteal phase
between gilts line with the high-average oocyte production
and randomly selected control line. The researchers identified
88 and 74 unique probes, representing 71 and 59 unique
genes, which were differentially expressed between lines in
the ovary and ovarian follicles of different size classes, respec-
tively. These studies were not directly comparable with our
data due to the differences in the experiment design, i.e., the
used treatment, type of tested tissues, and the phase of the
estrous cycle. However, they did observe changes in gene
expression of similar magnitude to this study.
Previous studies demonstrated the impact of adiponectin
on gene expression in the porcine ovary. However, the studies
were limited to a predetermined group of genes and not to the
entire transcriptome. Ledoux et al. (2006) showed the re-
sponse of granulosa cells derived from prepubertal gilts to
adiponectin. The authors observed higher levels of PTGS2
and VEGF gene expression in the cells primed with
adiponectin. Ledoux et al. (2006) also indicated a higher level
of PTGES and StAR gene expression and a decrease in the
expression of the P450 aromatase gene, which is in agreement
with our observations.
The analysis of gene ontology indicated that the expression
of many genes changed under the influence of adiponectin.
We noted a group of genes associated with several reproduc-
tive process GO terms, including reproductive developmental
process (GO:0003006), female pregnancy (GO:0007565), go-
nad development (GO:0008406), reproductive structure
development (GO:0048608), and development of primary sex-
ual characteristics (GO:0045137). Our study indicated for the
first time the role of adiponectin in the above-mentioned bio-
logical processes and identified genes potentially involved in
them.
The subject of our research was the luteal cells isolated in
the mid-luteal phase of the estrous cycle. The luteal phase
begins with the formation of the corpus luteum (CL) and ends
in either pregnancy or luteolysis. The mid-luteal phase is char-
acterized by the highest activity of CL, an endocrine gland
secreting estrogens and, most of all, significant amounts of
progesterone. Adiponectin had an inhibitory effect on in vitro
secretion of progesterone by porcine luteal cells on days 10 to
12 of the estrous cycle (Maleszka et al. 2014a). The effect of
adiponectin on ovarian basal progesterone secretion was also
suggested in studies on cows, rats, and humans (Chabrolle et
al. 2009; Mailard et al. 2010; Lagaly et al. 2008). Moreover,
the insulin-induced production of progesterone and estradiol
by bovine granulosa cells was significantly decreased as a
result of adiponectin treatment (Mailard et al. 2010). In the
study with bovine theca interna cells, Lagaly et al. (2008)
observed that adiponectin decreased LH and insulin-induced
production of progesterone. In this study, we observed chang-
es in the expression of genes which may be involved in the
regulation of steroid hormone secretion under adiponectin’s
influence. We noted an increase in the expression of the
AKR1C1 gene. A product of this gene is an enzyme involved
in the conversion of progesterone into its biologically inactive
metabolite 20α-hydroxyprogesterone (Penning 1997). This
enzyme has been detected, e.g., in the porcine ovary and
uterus, rat ovary and placenta, and human uterus (Seo et al.
2011; Akinola et al. 1997; Shiota et al. 1993; Zhang et al.
2000). Moreover, according to our results, AKR1C1 is a part
Fig. 2 Results of microarray
experiment validationwith qPCR.
Light grey bars indicate
microarray fold change; dark grey
bars indicate qPCR fold change.
Data are presented as means
± S.E.M. from four different
observations *p< 0.05;
**p< 0.01
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of two-gene groups associated with macromolecular complex
subunit organization (GO:0043933) and lipid localization
(GO:0010876). However, studies of other researchers indicat-
ed these functions only in hepatocytes (Stolz et al. 1993).
Another gene down-regulated by adiponectin which may be
involved in progesterone regulation is IL1β. Studies on the
effects of IL1β on progesterone production have been incon-
sistent. IL1β has been reported to suppress progesterone syn-
thesis in the CL of rats (Hurwitz et al. 1997), to stimulate
progesterone synthesis in human and pig luteal cells (Miceli
et al. 2003; Zmijewska et al. 2013), or to have no effect in
bovine luteal cells (Nishimura et al. 2004). The above
suggests that there are species-dependent differences in
the effects of IL1β on steroidogenesis. Adiponectin may
also negatively regulate progesterone secretion via an
observed decrease in the expression of visfatin. Earlier
studies demonstrated that recombinant human visfatin
(10 ng/ml) significantly increased IGF-1-induced proges-
terone and estradiol secretion in both primary human
granulosa cells and the human ovarian granulosa-like
tumor cell line (Reverchon et al. 2013).
Additionally, we found that NCOA3 and cAMP-response
element binding protein (CREBBP) genes, which are involved
in the regulation of steroid action, were up-regulated by
adiponectin. NCOA3 interacts with numerous nuclear hor-
mone receptors, like estrogen receptor alpha, thyroid hormone
receptor, and progesterone receptor, to enhance their transcrip-
tional activation (Bouras et al. 2001). Genetic disruption in
mice results in a pleiotropic phenotype showing dwarfism,
delayed puberty, reduced female reproductive function, and
blunted mammary gland development (Xu et al. 2000).
NCOA3 associates with the transcription factor CREBBP
and possesses histone acetyltransferase activity (Chen et al.
1997). It plays a key role in creating a multisubunit coactivator
complex, which probably acts via remodeling of chromatin.
The CREBBP gene is ubiquitously expressed and is involved
in the transcriptional coactivation of many different transcrip-
tion factors. This gene is known to play critical roles in em-
bryonic development, growth control, and homeostasis by
coupling chromatin remodeling to transcription factor recog-
nition (Ogryzko et al. 1996). It seems that adiponectin may
have an indirect effect on the processes involved in the
coactivation of different nuclear receptors, through changes
in the expression of these two genes.
Another group of genes affected by adiponectin comprises
those connected to prostaglandin synthesis. Prostaglandins
have an important role in the regulation of the estrous cycle
and successful implantation in pigs (Spencer and Bazer 2004).
PTGS and PTGS2 are responsible for the formation of
prostanoids, including prostaglandins (Sawdy et al. 2000;
Charpigny et al. 1997). In our study, we noted the up-
regulation of PTGS2 caused by adiponectin treatment. This
may have an implication in reproductive events such as
ovulation, luteolysis, implantation, and parturition. Previous
research noted an increase in both enzymes’ mRNAs content
after stimulation with adiponectin (Ledoux et al. 2006).
Adipokine may have an influence on female pregnancy
(GO:0007565), by an increase in the expression of PTGS2,
chloride intracellular channel 5 (CLIC5), and the placental
growth factor (PGF) gene. The observed expression of
PTGS2 in the ovary may suggest the autocrine action of pros-
taglandins, including prostaglandins E and F2α, on luteiniza-
tion and luteolysis of ovarian cells. Another gene involved in
this process,CLIC5, is involved in chloride ion transport with-
in various subcellular compartments (Berryman and Bretscher
2000). CLIC5 appears to be an important component of many
actin-rich structures in cells. Placenta growth factor (PGF) is
another gene affected by adiponectin. This suggests that this
adipokine may regulate cell proliferation (GO:0008283) as
well as endothelial cell proliferation (GO:0001938), via
PGF expression modulation. PGF is a key molecule in angio-
genesis and vasculogenesis during embryogenesis. The main
source of PGF during pregnancy is the placental trophoblast.
It stimulates the proliferation, migration, and activation of
endothelial cells (Vuorela et al. 1997; Maglione et al. 1991).
Adiponectin is also reported to have angiogenic activity
(Ouchi et al. 2004) and therefore could be essential in the
establishment of the vascular system in the ovary and poten-
tially in the developing placenta, presumably by the stimula-
tion of angiogenic factors, such as PGF.
Knowledge of the effects of adiponectin on the develop-
ment of the ovaries is limited mainly to oocytes’ maturation
and vascularization (Chappaz et al. 2008; Ledoux et al. 2006).
Adiponectin addition to the medium induced meiotic matura-
tion of oocytes derived from large follicles, but not those de-
rived from small follicles (Chappaz et al. 2008). The growth
and regression of ovarian tissues are accompanied by equally
rapid changes in their vascular vessel network. The main role
in ovarian angiogenesis may be played by VEGF, which stim-
ulates vessel growth and increases endothelial permeability,
thus favoring the uptake of nutrients by the developing tissues
(Gomez et al. 2002). We observed an up-regulatory effect of
adiponectin on this gene expression, which may suggest that
the adipokine stimulates the above process. The above suggest
that adiponectin may affect blood vessel remodeling
(GO:0001974) and positive regulation of endothelial cell
proliferation (GO:0001938) via VEGF expression modula-
tion. In the group of genes involved in ovary development,
we also noted OSR1 and SF1. These genes were up-regulated
by adiponectin in this study. OSR1 is a transcription factor
which participates in the normal development of body parts.
In mutant mouse embryos with an inactive OSR1 gene, the
complete agenesis of adrenal glands, metanephric kidneys,
and gonads as well as defects in pericardium formation were
observed (Wang et al. 2005). The SF1 gene encodes a nuclear
pre-mRNA splicing factor. The SF1 protein is a critical
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regulator of reproduction, modulating the transcription of key
genes involved in sexual development and reproduction. Its
targets include genes at every level of the HPG axis, as well as
many genes involved in gonadal and adrenal steroidogenesis
(Jamesson 2004).Mice with granulosa cell-specific condition-
al knockout of SF1 are sterile and have fewer follicles, a lack
of corpora lutea, and hemorrhagic cysts (Cordts et al. 2011).
These characteristics indicate the important role of SF1 in the
development of ovaries, which directly determines the proper
functioning of this structure. This may suggest that
adiponectin is also responsible for the proper development
of reproductive organs. Also, the same group, i.e., VEGF,
OSR1, and SF1 genes, was identified to be involved in anoth-
er two biological processes: reproductive structure
development (GO:0048608) and the development of primary
sexual characteristics (GO:0045137). Changes in the plasma
adiponectin concentration during sexual maturation seem to
be significant evidence for its involvement in the above pro-
cesses (Böttner et al. 2004). Our study provides evidence that
adiponectin may affect sexual development via an influence
on the expression of, e.g., VEGF, OSR1, and SF1 genes.
In conclusion, our study was the first experiment to dem-
onstrate the effect of adiponectin on global gene expression in
the cells of the corpora lutea during the mid-luteal phase. We
identified a group of genes connected to reproductive system
function whose expression was affected by the studied
hormone. These results provide a basis for future work
describing the detailed interactions and relationships
explaining local regulation of adiponectin actions in the ovary
of pigs.
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